SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
PIMCO Corporate & Income Strategy Fund (PCN) trades at a trailing P/E of 8.5. Trailing earnings yield is 11.83%. PEG 0.58 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (8.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.58); earnings yield beats bond yields (11.83%).
- PEG Ratio 0.58 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 11.83% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PCN
Valuation Multiples
P/E (TTM)8.5
Forward P/EN/A
PEG Ratio0.58
Forward PEGN/A
P/B Ratio0.00
P/S Ratio7.51
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.42
Book Value / Share$0.00
Revenue / Share$1.60
FCF / Share$0.00
Yields & Fair Value
Earnings Yield11.83%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.39 |
$53.83M |
$15.07M |
28% |
| 2017 |
$2.81 |
$110.34M |
$110.05M |
99.7% |
| 2018 |
$0.96 |
$37.83M |
$37.54M |
99.3% |
| 2019 |
$1.39 |
$55.64M |
$55.28M |
99.4% |
| 2020 |
$-0.77 |
$-30.6M |
$-30.79M |
- |
| 2021 |
$3.01 |
$120.95M |
$120.75M |
99.8% |
| 2022 |
$-1.83 |
$120.46M |
$-87.62M |
-72.7% |
| 2023 |
$1.05 |
$42.28M |
$42.05M |
99.5% |
| 2024 |
$1.24 |
$72.91M |
$72.65M |
99.6% |
| 2025 |
$1.42 |
$98.05M |
$95.15M |
97% |
